跳至主要内容
临床试验/CTRI/2010/091/001459
CTRI/2010/091/001459已完成3 期

A Comparative, Randomized, Double Blind, Multicentric, Prospective Clinical Study to evaluate the efficacy, safety and tolerability of Tafluprost Ophthalmic solution 15 mcg/ml Vs. Latanoprost eye drops 0.005 % in patients with Glaucoma.

Ajanta Pharma Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with diagnosis of glaucoma.

排除标准

  • Pregnant or nursing females.
  • Patients with exfoliation glaucoma and neovascular glaucoma.
  • Patients with diabetic retinopathy.
  • Patients with advanced visual field loss (MD <-15dB).
  • Excessive myopia (<-6D).
  • Any corneal abnormality or other condition preventing reliable applanation tonometry.
  • Presence of any external disease and inflammation of the eye.
  • History of refractive surgery.
  • History of laser trabeculoplasty, filtering surgery, trabeculotomy, cataract surgery, and other intraocular surgery.

研究者

相似试验